Ready-to-Use PCR Panels, 84 miRNA assays targeting the mentioned specific research focus, reference miRNAs and spike-in control assays
96-well format: 4 panel sets (4 plates in total)
384-well format: 8 panel sets (2 plates in total)
96-well format: 4 panel sets (4 plates in total)
384-well format: 8 panel sets (2 plates in total)
Target List
Leukemia & Lymphoma
Hodgkin’s Lymphoma
mmu-miR-129-5pmmu-miR-130a-3pmmu-miR-132-3pmmu-miR-134-5pmmu-miR-135a-5pmmu-miR-135b-5pmmu-miR-138-5pmmu-miR-140-5pmmu-miR-142a-3pmmu-miR-142a-5pmmu-miR-145a-5pmmu-miR-147-3pmmu-miR-15b-5pmmu-miR-181a-5pmmu-miR-183-5pmmu-miR-185-5pmmu-miR-200a-3pmmu-miR-205-5pmmu-miR-20b-5pmmu-miR-21a-5pmmu-miR-23b-3pmmu-miR-26a-5pmmu-miR-26b-5pmmu-miR-27a-3pmmu-miR-28a-5pmmu-miR-29b-3pmmu-miR-30c-5pmmu-miR-31-5pmmu-miR-325-3pmmu-miR-335-5pmmu-miR-34a-5pmmu-miR-34c-5pmmu-miR-9-5p
Primary Effusion Lymphoma
mmu-miR-103-3pmmu-miR-106a-5pmmu-miR-140-5pmmu-miR-142a-3pmmu-miR-148a-3pmmu-miR-152-3pmmu-miR-16-5pmmu-miR-182-5pmmu-miR-186-5pmmu-miR-191-5pmmu-miR-194-5pmmu-miR-19a-3pmmu-miR-210-3pmmu-miR-23b-3pmmu-miR-26a-5pmmu-miR-29b-3pmmu-miR-30e-5pmmu-miR-320-3pmmu-miR-34a-5p
T Cell Leukemia
mmu-miR-106a-5pmmu-miR-132-3pmmu-miR-18b-5pmmu-miR-19b-3pmmu-miR-20b-5p
Other Leukemia & Lymphoma miRNAs
mmu-miR-15a-5p
Autoimmune Disorders
Idiopathic Thrombocytopenic Purpura
mmu-miR-196a-5pmmu-miR-214-3pmmu-miR-298-5pmmu-miR-383-5pmmu-miR-409-3p
Systemic Lupus Erythematosus
mmu-miR-142a-3pmmu-miR-184-3pmmu-miR-196a-5pmmu-miR-21a-5pmmu-miR-298-5pmmu-miR-383-5pmmu-miR-409-3p
Inflammatory Responses
IL-1 Induced Inflammatory Response
mmu-let-7g-5pmmu-miR-146a-5pmmu-miR-146b-5pmmu-miR-195a-5pmmu-miR-26b-5pmmu-miR-299a-3p
Inflammation Mediators
mmu-miR-155-5pmmu-miR-203-3p
Macrophage Inflammatory Response
mmu-miR-132-3pmmu-miR-155-5p
Vascular Inflammation
mmu-miR-155-5pmmu-miR-21a-5p
Other Inflammatory Response miRNAs
mmu-miR-125a-5p
Innate Immune Response
mmu-miR-105mmu-miR-146a-5pmmu-miR-146b-5pmmu-miR-19a-3pmmu-miR-19b-3pmmu-miR-299a-3p
Induced in Monocytes by Lipopolysaccharide (LPS)
mmu-let-7e-5pmmu-miR-132-3pmmu-miR-146a-5pmmu-miR-146b-5pmmu-miR-155-5pmmu-miR-187-3pmmu-miR-9-5p
Immune Cells
B Cell Differentiation
mmu-miR-150-5p
Invariant Natural Killer Cell Development
mmu-miR-150-5pmmu-miR-155-5p
Lymphocytes
mmu-let-7e-5pmmu-miR-125a-5pmmu-miR-125b-5pmmu-miR-126a-3pmmu-miR-142a-5pmmu-miR-145a-5pmmu-miR-146a-5pmmu-miR-148a-3pmmu-miR-195a-5pmmu-miR-207mmu-miR-223-3pmmu-miR-451ammu-miR-493-3pmmu-miR-574-3p
Monocytopoiesis
mmu-miR-106a-5pmmu-miR-20a-5p
Natural Regulatory T Cells
mmu-miR-103-3pmmu-miR-142a-5pmmu-miR-149-5pmmu-miR-150-5pmmu-miR-15b-5pmmu-miR-16-5pmmu-miR-191-5pmmu-miR-19a-3pmmu-miR-214-3pmmu-miR-21a-5pmmu-miR-223-3pmmu-miR-26a-5pmmu-miR-27b-3pmmu-miR-29c-3pmmu-miR-30b-5pmmu-miR-30c-5pmmu-miR-30e-5p
Targets Relevant Genes
Targets Cytokines
mmu-miR-98-5p
Targets Interferons & Receptors
mmu-miR-146a-5pmmu-miR-223-3p
Targets Interleukins
mmu-miR-106a-5pmmu-miR-146a-5pmmu-miR-155-5pmmu-miR-15a-5pmmu-miR-181a-5pmmu-miR-223-3p
Targets STAT3
mmu-miR-18a-5p
Targets STAT4
mmu-miR-19a-3p
Targets STAT5
mmu-miR-19b-3p
Targets STAT6
mmu-miR-20a-5p
Targets TNF Alpha
mmu-miR-155-5p
Signal Transduction
IL6 / STAT3 Signaling
mmu-let-7a-5pmmu-let-7c-5pmmu-let-7d-5pmmu-miR-21a-5p
NFκB Signaling
mmu-miR-146a-5pmmu-miR-155-5p